CHICAGO — Five years after treatment, patients with severe aortic stenosis had comparable rates of all-cause mortality or disabling stroke, whether they received transcatheter aortic valve replacement (TAVR) or surgery, according to midterm results from the Evolut Low Risk trial. The randomized, multicenter, international study compared the safety and efficacy of the Evolut TAVR system […]
The post 5-Year TAVR, Surgery Outcomes Similar in Low-Risk Patients first appeared on News Health.
Author : News Health
Publish date : 2025-04-02 20:55:00
Copyright for syndicated content belongs to the linked Source.